Key result
Repeated surgery and chemotherapy fail to prevent multiple recurrences and rare metastases in extraskeletal osteosarcoma.
Why the study?
Extraskeletal osteosarcoma is a rare, aggressive malignancy with atypical clinical presentation and no current consensus on the optimal treatment strategy.
Case Report (n=1)
Extraskeletal osteosarcoma is a rare, aggressive malignancy with a poor prognosis, especially when metastasizing to distal soft tissues.
May warrant heightened surveillance for rare metastases in extraskeletal osteosarcoma; leaves open optimal strategies for refractory disease.
Background: Extraskeletal osteosarcoma (ESOS) is a rare and aggressive malignancy, comprising approximately 1% of all soft tissue sarcomas and 4.3% of all osteosarcomas. It predominantly affects individuals between the ages of 48 and 60, with a slightly higher incidence observed in males compared to females. The clinical diagnosis of ESOS poses a significant challenge due to its atypical presentation and overlap with other soft tissue neoplasms. Despite advances in diagnostic imaging and histopathological techniques, there is currently no consensus on the optimal treatment strategy. Case presentation: We report a case of a 64-year-old Chinese woman with ESOS of the left knee for 7 years, who experienced multiple recurrences after surgical resection, accompanied by systemic multiple soft tissue metastases and lung metastases. Initially, the patient found a painless mass in the left knee, which was diagnosed as a benign soft tissue mass at a local hospital and surgically removed. However, two years after the surgery, a mass recurred around the left knee and was larger than before, prompting the patient to seek treatment at our department. The patient underwent standard surgical treatment in our department, and postoperative histopathology, genetic testing, and immunohistochemical examination all confirmed the diagnosis of ESOS. Over the course of 5 years, the patient experienced multiple recurrences, and we attempted surgical treatment combined with chemotherapy and targeted therapy. Ultimately, due to multiple tumor ruptures in the left lower limb, severe pain, and sleep disorders, the patient decided to undergo left hip disarticulation surgery. Conclusion: The diagnosis and treatment of ESOS are challenging and require multimodal examination, including histological and immunohistochemical analysis. ESOS is rare, especially when it metastasizes to the distal soft tissues of the primary lesion site, which may portend a poorer clinical outcome compared to pure pulmonary metastasis. Despite current therapeutic interventions, this case still emphasizes its aggressiveness and poor prognosis.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) conducted a case report in Extraskeletal osteosarcoma (ESOS) (n=1). Surgical resection, chemotherapy, and targeted therapy was evaluated on Clinical outcome (recurrence and metastasis). A 64-year-old woman with extraskeletal osteosarcoma experienced multiple recurrences and rare distal soft tissue metastases despite repeated surgical resections, chemotherapy, and targeted therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: